Navigation Links
Sunpeaks Ventures Announces Second Quarter 2012 Results
Date:8/14/2012

SILVER SPRING, Md., Aug. 14, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") on 8/14/12 reported its financial results for the second quarter ended June 30, 2012:

Second Quarter Financial Details and Operating Summary

  • Gross sales for the second quarter were $1.23 mln on a non-adjusted basis. Gross sales for the year-to-date were $2.19mln on a non-adjusted basis. Second quarter revenue in 2012 represents a 4,000% increase over revenue for the same quarter in 2012, and a 29% increase over revenue for the  first quarter of 2012.
  • The Company continues to grow its pharmaceutical license base and is now licensed in 30 states.
  • The Company continues to make a significant investment in its IT infrastructure, which management believes will stream line sales processes and lead to greater efficiencies.
  • The Company attended the ERCM Marketgate, Vitamin, Diet and Nutrition conference in Ft. Lauderdale, FL, and as a result expects to enter into new agreements regarding the distribution of Clotamin sometime in the second half of 2012.

About Sunpeaks

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Files Defamation Lawsuit
2. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
3. Pappas Ventures Names Pat Gage to Scientific Advisory Board
4. SJF Ventures Completes Oversubscribed Series A Round for BioSurplus
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , January 17, 2017 ... 2016;11(Suppl. 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... Published recently in European Neurological ... touchNEUROLOGY, Catherine Amey reports that despite ...
(Date:1/17/2017)... , Jan. 17, 2017  Tetra Discovery ... M. Erwin as Vice President, Clinical Operations. ... he was Executive Director, Clinical Project Management. ... years of experience in global clinical research planning ... successful growth-stage clinical operation build-outs and development partnerships," ...
(Date:1/17/2017)... WHIPPANY, N.J. , Jan. 17, 2017  Bayer today ... President of its Pharmaceuticals business in the Americas, comprising ... , Central and Latin America . In ... , member of the Board of Management of Bayer AG ... a strategic and highly respected leader in the pharmaceutical industry ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... ... and eliminate cyber threats in real-time, today announced a strategic partnership with ... Selangor, Malaysia. Joining other Seceon partners, TechLab Security has become a strategic partner ...
(Date:1/17/2017)... ... 2017 , ... Today, FloSports , a global leader in live digital ... part of a long-term extension of their media partnership. The partnership, which began in ... the sport’s premier events exclusively on FloWrestling.com as well as usage of the FloArena ...
(Date:1/16/2017)... ... 2017 , ... Gym Source, America’s leading retailer of premium residential and commercial ... Jersey. , “We are elated to be opening this new showroom,” explains Tom Richard, ... give clients a seamless and motivating shopping experience.” , Every fitness journey is unique, ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... today announced the addition of Victor Giamos, MD to their medical staff, ... and Managing Partner at North Shore Eye Care, a division of SightMD. Dr. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Date aired: January 9, 2017 ... Sharon Kleyne, America’s leading water educator, researcher and advocate welcomed health activist, author, ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on ...
Breaking Medicine News(10 mins):